Skip to main content
. 1997 Mar;56(3):201–204. doi: 10.1136/ard.56.3.201

Figure 1  .

Figure 1  

Changes in the circumference of the affected limbs (together with mean and standard deviation) two and four weeks after the beginning of the trial in the patients randomly assigned to either alendronate (right panel) or placebo (left panel) at the beginning of the study. At week 2 both groups of patients had a treatment course with intravenous alendronate.